Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

Clinical trial NCT06239194 · RECRUITING

Trial details

NCT number: NCT06239194
Sponsor: ModeX Therapeutics, An OPKO Health Company
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Biliary Tract Cancer Breast Cancer Cervical Cancer Colon Cancer Endometrial Cancer Esophageal Cancer Gastric Cancer GastroEsophageal Cancer Head and Neck Cancer Hepatocellular Cancer Non-small Cell Lung Cancer Pancreatic Cancer

Start date: 2024-06-12
Primary completion: 2028-08-01
Enrollment: 285

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.